These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

327 related articles for article (PubMed ID: 20930717)

  • 1. D2 Thr92Ala and PPARγ2 Pro12Ala polymorphisms interact in the modulation of insulin resistance in type 2 diabetic patients.
    Estivalet AA; Leiria LB; Dora JM; Rheinheimer J; Bouças AP; Maia AL; Crispim D
    Obesity (Silver Spring); 2011 Apr; 19(4):825-32. PubMed ID: 20930717
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pro12Ala polymorphism of the peroxisome proliferator-activated receptor-gamma gene in first-degree relatives of subjects with polycystic ovary syndrome.
    Yilmaz M; Ergün MA; Karakoç A; Yurtçu E; Yetkin I; Ayvaz G; Cakir N; Arslan M
    Gynecol Endocrinol; 2005 Oct; 21(4):206-10. PubMed ID: 16316841
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between Pro12Ala polymorphism of the PPAR-gamma2 gene and insulin sensitivity in Brazilian patients with type-2 diabetes mellitus.
    Tavares V; Hirata RD; Rodrigues AC; Monte O; Salles JE; Scalissi N; Speranza AC; Hirata MH
    Diabetes Obes Metab; 2005 Sep; 7(5):605-11. PubMed ID: 16050954
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lack of association between the Pro12Ala polymorphism in PPAR-gamma2 gene and body weight changes, insulin resistance and chronic diabetic complications in obese patients with type 2 diabetes.
    Stefanski A; Majkowska L; Ciechanowicz A; Frankow M; Safranow K; Parczewski M; Pilarska K
    Arch Med Res; 2006 Aug; 37(6):736-43. PubMed ID: 16824933
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of Pro12Ala polymorphism in the peroxisome proliferator-activated receptor gamma2 gene with small dense low-density lipoprotein in the general population.
    Hamada T; Kotani K; Tsuzaki K; Sano Y; Murata T; Tabata M; Sato S; Sakane N
    Metabolism; 2007 Oct; 56(10):1345-9. PubMed ID: 17884443
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sibling-based association study of the PPARgamma2 Pro12Ala polymorphism and metabolic variables in Chinese and Japanese hypertension families: a SAPPHIRe study. Stanford Asian-Pacific Program in Hypertension and Insulin Resistance.
    Chuang LM; Hsiung CA; Chen YD; Ho LT; Sheu WH; Pei D; Nakatsuka CH; Cox D; Pratt RE; Lei HH; Tai TY
    J Mol Med (Berl); 2001 Nov; 79(11):656-64. PubMed ID: 11715069
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Pro12Ala polymorphism of the PPAR-gamma2 gene affects associations of fish intake and marine n-3 fatty acids with glucose metabolism.
    Ylönen SK; Salminen I; Lyssenko V; Virtanen SM; Groop L; Aro A; Saloranta C;
    Eur J Clin Nutr; 2008 Dec; 62(12):1432-9. PubMed ID: 17700648
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of Pro12Ala polymorphism of peroxisome proliferator-activated receptor gamma2 gene on rosiglitazone response in type 2 diabetes.
    Kang ES; Park SY; Kim HJ; Kim CS; Ahn CW; Cha BS; Lim SK; Nam CM; Lee HC
    Clin Pharmacol Ther; 2005 Aug; 78(2):202-8. PubMed ID: 16084854
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of the PPAR-gamma2 Pro12Ala and ACE I/D polymorphisms on insulin sensitivity and training effects in healthy offspring of type 2 diabetic subjects.
    Østergård T; Ek J; Hamid Y; Saltin B; Pedersen OB; Hansen T; Schmitz O
    Horm Metab Res; 2005 Feb; 37(2):99-105. PubMed ID: 15778927
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IRS1, KCNJ11, PPARgamma2 and HNF-1alpha: do amino acid polymorphisms in these candidate genes support a shared aetiology between type 1 and type 2 diabetes?
    Johansen A; Jensen DP; Bergholdt R; Mortensen HB; Pociot F; Nerup J; Hansen T; Pedersen O;
    Diabetes Obes Metab; 2006 Jan; 8(1):75-82. PubMed ID: 16367885
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PPAR-gamma2 Pro12Ala variant is associated with greater insulin sensitivity in childhood obesity.
    Buzzetti R; Petrone A; Caiazzo AM; Alemanno I; Zavarella S; Capizzi M; Mein CA; Osborn JA; Vania A; di Mario U
    Pediatr Res; 2005 Jan; 57(1):138-40. PubMed ID: 15531738
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of Pro12Ala polymorphism in peroxisome proliferator-activated receptor gamma with Pre-diabetic phenotypes: meta-analysis of 57 studies on nondiabetic individuals.
    Tönjes A; Scholz M; Loeffler M; Stumvoll M
    Diabetes Care; 2006 Nov; 29(11):2489-97. PubMed ID: 17065690
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Pro12Ala polymorphism in PPAR gamma2 may confer resistance to type 2 diabetes.
    Hara K; Okada T; Tobe K; Yasuda K; Mori Y; Kadowaki H; Hagura R; Akanuma Y; Kimura S; Ito C; Kadowaki T
    Biochem Biophys Res Commun; 2000 Apr; 271(1):212-6. PubMed ID: 10777704
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence for interaction between PPARG Pro12Ala and PPARGC1A Gly482Ser polymorphisms in determining type 2 diabetes intermediate phenotypes in overweight subjects.
    Ruchat SM; Weisnagel SJ; Vohl MC; Rankinen T; Bouchard C; Pérusse L
    Exp Clin Endocrinol Diabetes; 2009 Oct; 117(9):455-9. PubMed ID: 19536736
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interaction between PPARG Pro12Ala and ADIPOQ G276T concerning cholesterol levels in childhood obesity.
    Johansson LE; Danielsson P; Norgren S; Marcus C; Ridderstråle M
    Int J Pediatr Obes; 2009; 4(2):119-25. PubMed ID: 18645733
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pro12Ala polymorphism of the peroxisome proliferator-activated receptor-gamma2 (PPARgamma-2) gene is associated with greater insulin sensitivity and decreased risk of type 2 diabetes in an Iranian population.
    Meshkani R; Taghikhani M; Larijani B; Bahrami Y; Khatami S; Khoshbin E; Ghaemi A; Sadeghi S; Mirkhani F; Molapour A; Adeli K
    Clin Chem Lab Med; 2007; 45(4):477-82. PubMed ID: 17439324
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of the PRO12ALA polymorphism of the PPAR-gamma2 gene with oxidized low-density lipoprotein and cardiolipin autoantibodies in nondiabetic and type 2 diabetic subjects.
    Niskanen L; Lindi V; Erkkilä A; Sivenius K; Luoma J; Ylä-Herttuala S; Laakso M; Uusitupa MI
    Metabolism; 2003 Feb; 52(2):213-7. PubMed ID: 12601635
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The type 2 deiodinase A/G (Thr92Ala) polymorphism is associated with decreased enzyme velocity and increased insulin resistance in patients with type 2 diabetes mellitus.
    Canani LH; Capp C; Dora JM; Meyer EL; Wagner MS; Harney JW; Larsen PR; Gross JL; Bianco AC; Maia AL
    J Clin Endocrinol Metab; 2005 Jun; 90(6):3472-8. PubMed ID: 15797963
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The common PPAR-gamma2 Pro12Ala variant is associated with greater insulin sensitivity.
    Buzzetti R; Petrone A; Ribaudo MC; Alemanno I; Zavarella S; Mein CA; Maiani F; Tiberti C; Baroni MG; Vecci E; Arca M; Leonetti F; Di Mario U
    Eur J Hum Genet; 2004 Dec; 12(12):1050-4. PubMed ID: 15367918
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of two common polymorphisms of peroxisome proliferator-activated receptor-gamma gene on metabolic syndrome.
    Rhee EJ; Oh KW; Lee WY; Kim SY; Oh ES; Baek KH; Kang MI; Kim SW
    Arch Med Res; 2006 Jan; 37(1):86-94. PubMed ID: 16314192
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.